These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3487905)

  • 1. Cerebrospinal fluid and serum immune complex in acute inflammatory polyneuritis. Detection by Clq binding assay.
    Antoine JC; Michel D; Lamelin JP; Laurent B; Schott B
    Acta Neurol Scand; 1986 May; 73(5):477-80. PubMed ID: 3487905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and plasma fibronectin binds to complement reacted immune complexes primarily via Clq.
    Baatrup G; Svehag SE
    Scand J Immunol; 1986 Nov; 24(5):583-90. PubMed ID: 3097811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes after cadaver kidney transplantation.
    Kaden J; Falck P; Groth J; Mebel M
    Nephron; 1981; 28(3):127-32. PubMed ID: 7029320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in patients with multiple sclerosis. A longitudinal study of serum and CSF by C1q and platelet binding tests.
    Arnadottir T; Kekomäki R; Lund GA; Reunanen M; Salmi AA
    J Neurol Sci; 1982 Sep; 55(3):273-83. PubMed ID: 6982312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in chronic myeloid leukemia patients at various stages of the disease.
    Saranath D; Advani S; Gangal S
    Leuk Res; 1983; 7(6):771-7. PubMed ID: 6607388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary studies on the detection, isolation and partial characterization of Clq-containing IgM immune complexes in sera of patients with primary biliary cirrhosis.
    Willson RA; Balint J
    Immunol Lett; 1988 Apr; 17(4):303-9. PubMed ID: 3259541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia.
    Latov N; Gross RB; Kastelman J; Flanagan T; Lamme S; Alkaitis DA; Olarte MR; Sherman WH; Chess L; Penn AS
    Neurology; 1981 Dec; 31(12):1530-4. PubMed ID: 7198204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for arginine residues in the immunoglobulin-binding sites of human Clq.
    Comis A; Easterbrook-Smith SB
    Biochim Biophys Acta; 1985 Sep; 842(1):45-51. PubMed ID: 3876114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune complexes in serum and cerebrospinal fluid of multiple sclerosis patients and patients with other neurological diseases.
    Salmi A; Ziola B; Reunanen M; Julkunen I; Wager O
    Acta Neurol Scand; 1982 Jul; 66(1):1-15. PubMed ID: 7113673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating antigen-antibody complexes in onchocerciasis.
    Steward MW; Sisley B; Mackenzie CD; El Sheikh H
    Clin Exp Immunol; 1982 Apr; 48(1):17-24. PubMed ID: 6979445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of the fluid phase C1q binding assay. The effect of endogenous C1q on the precipitation and detection of an immune complex model.
    Jacobs RJ; Mocharla R
    J Immunol Methods; 1988 May; 109(2):265-75. PubMed ID: 3258897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability to activate complement is not required for the detection of immune complexes by the fluid-phase C1q binding assay.
    Fiocco GP; Davis JS; Burge JJ
    Arthritis Rheum; 1985 Feb; 28(2):222-5. PubMed ID: 3871617
    [No Abstract]   [Full Text] [Related]  

  • 14. Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
    Kilpatrick JM; Virella G
    Diagn Immunol; 1983; 1(2):57-63. PubMed ID: 6388965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
    Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
    J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis.
    Lambert PH; Berney M; Kazyumba G
    J Clin Invest; 1981 Jan; 67(1):77-85. PubMed ID: 6969733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interference of fibrinogen and heparin with the determination of circulating immune complexes in the C1q-binding assay.
    Faaber P; Capel PJ; Koene RA
    Clin Exp Immunol; 1981 Sep; 45(3):590-4. PubMed ID: 6978209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune complexes in coccidioidomycosis. Correlation with disease involvement.
    Cox RA; Pope RM; Stevens DA
    Am Rev Respir Dis; 1982 Sep; 126(3):439-43. PubMed ID: 6982011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of virus and antibody containing immune complexes from mink with Aleutian disease by affinity chromatography of equine complement clq.
    Burger D; Sriranganathan N; McDonald TL; Gorham JR
    Am J Vet Res; 1983 Jan; 44(1):86-90. PubMed ID: 6297342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of Clq binding activity by IgM rheumatoid factor.
    Zilberfarb JL; Andrews BS; Young AC; Davis JS
    J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.